As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, addressing mammography's limitations in dense breast tissue. The test achieved 92.3 ...

An Orange County hospital is turning to artificial intelligence, giving radiologists an extra edge to detect breast cancer in ...

WINSTON-SALEM, N.C. — Researchers at Wake Forest University School of Medicine are developing a new at-home device they hope will help people identify potential skin cancer risks earlier and encourage ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

Pancreatic cancer is not a disease that reveals itself easily, at least not initially. The pancreas is tucked deep in the abdomen, behind the stomach, so tumours aren’t easy to see or feel. A person ...

In many regions, doctors practice in settings with limited medical resources. Advanced tests, specialist support, and expert ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

The ability of Raman spectroscopy to identify molecular-level spectral fingerprints has made it an attractive route to diagnostic information and identification of early-stage tumors, especially in ...

The monarch was diagnosed with cancer in 2024. King Charles III announced in a video message Friday that he will be reducing his cancer treatment schedule in the new year, citing his early diagnosis, ...